Thursday, 5 November 2026European Markets
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· January 28, 2026

S&P 500 Posts a Record High on Tech Strength and Solid Corporate Earnings

View original at nasdaq.com
S&P 500 Posts a Record High on Tech Strength and Solid Corporate Earnings The S&P 500 Index ($SPX) (SPY) on Tuesday closed up +0.41%, the Dow Jones Industrials Index ($DOWI) (DIA) closed down -0.83%, and the Nasdaq 100 Index ($IUXX) (QQQ) closed up +0.88%…
Opening lines of the source · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • HCA Healthcare reported Q4 net income of $1.88 billion, better than consensus of $1.73 billion

    80% confidence
  • Roper Technologies forecasts 2026 adjusted EPS continuing operations of $21.30 to $21.55, below consensus of $21.62

    80% confidence
  • General Motors forecasts full-year adjusted EPS of $11.00 to $13.00, the midpoint above consensus of $11.79

    80% confidence
  • UnitedHealth Group forecasts a decline in 2026 revenue, the first annual contraction in more than 30 years

    80% confidence
  • General Motors reported Q4 adjusted EPS of $2.51, better than consensus of $2.28

    80% confidence
  • S&P earnings growth is expected to climb by +8.4% in Q4

    80% confidence
  • Brown & Brown reported Q4 revenue of $1.61 billion, weaker than expectations of $1.65 billion

    80% confidence
  • Sanmina forecasts Q2 revenue of $3.1 billion to $3.4 billion, weaker than consensus of $3.51 billion

    80% confidence
  • Deutsche Bank upgraded CoreWeave stock to buy from hold with a price target of $140

    80% confidence
  • RTX Corp reported Q4 adjusted sales of $24.24 billion, well above consensus of $22.63 billion

    80% confidence
  • Micron Technology plans to invest $24 billion in Singapore and expand its memory-chip capacity

    80% confidence
  • Excluding the Magnificent Seven megacap technology stocks, Q4 earnings are expected to increase by +4.6%

    80% confidence
  • Agilysys reported Q3 adjusted EPS of 42 cents, weaker than consensus of 46 cents

    80% confidence
  • Applied Industrial Technologies reported Q2 net sales of $1.16 billion, below consensus of $1.17 billion

    80% confidence
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Oncology Data Season and Biotech Capital Allocation: ESMO Readouts, Ivonescimab PDUFA, and Diverging Corporate Moves
Late-2026 biotech is driven by a dense catalyst calendar. ESMO 2026 delivers data from ivonescimab, Enhertu, R-DXd and bemarituzumab, and the FDA has set a 14 Nov PDUFA date for the ivonescimab BLA. Capital allocation is diverging. Krystal Biotech authorized a $400M buyback while lowering FY2026 spend guidance and pushing milestones into 2027. Spago is moving to delist from Nasdaq First North. The facts are clinical and corporate events, not AI or fintech, so the finance angle is limited to capital markets (buybacks, guidance, delistings, regulatory timelines).
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,995
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,995 facts checked against source5,549 source documents archived
Query this data → isubstrate.com